Abstract
Seventeen patients with cystathionine synthase deficiency homocystinuria were examined clinically and neurophysiologically for evidence of sensory neuropathy. All had received high dose pyridoxine (vitamin B-6) for many years. Absence of neurological disturbance in all cases suggests long term treatment with pyridoxine in the dosages used in homocystinuric patients is not harmful.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cohen M., Bendich A. Safety of pyridoxine--a review of human and animal studies. Toxicol Lett. 1986 Dec;34(2-3):129–139. doi: 10.1016/0378-4274(86)90202-x. [DOI] [PubMed] [Google Scholar]
- Lumeng L., Lui A., Li T. K. Plasma content of B6 vitamers and its relationship to hepatic vitamin B6 metabolism. J Clin Invest. 1980 Oct;66(4):688–695. doi: 10.1172/JCI109906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parry G. J., Bredesen D. E. Sensory neuropathy with low-dose pyridoxine. Neurology. 1985 Oct;35(10):1466–1468. doi: 10.1212/wnl.35.10.1466. [DOI] [PubMed] [Google Scholar]
- Schaumburg H., Kaplan J., Windebank A., Vick N., Rasmus S., Pleasure D., Brown M. J. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med. 1983 Aug 25;309(8):445–448. doi: 10.1056/NEJM198308253090801. [DOI] [PubMed] [Google Scholar]
- Serfontein W. J., Ubbink J. B., De Villiers L. S., Rapley C. H., Becker P. J. Plasma pyridoxal-5-phosphate level as risk index for coronary artery disease. Atherosclerosis. 1985 Jun;55(3):357–361. doi: 10.1016/0021-9150(85)90113-3. [DOI] [PubMed] [Google Scholar]